Citrini Bets on Life Sciences After Claude AI Drug Study

Life sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic PBC’s Claude Science.

First reported by Bloomberg. This page is a short excerpt; the full text is theirs.